1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Global Cell and Tissue Culture Supplies Industry

Global Cell and Tissue Culture Supplies Industry

  • June 2014
  • -
  • Global Industry Analysts
  • -
  • 232 pages

This report analyzes the worldwide markets for Cell and Tissue Culture Supplies in US$ Thousands by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 67 companies including many key and niche players such as -

Affymetrix, Inc.
AMRESCO, Inc.
BD Biosciences
Corning, Inc.
EMD Millipore

Table Of Contents

Global Cell and Tissue Culture Supplies Industry



I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Cell/Tissue Culture Media, Sera and Reagents I-3
Media I-3
Sera I-4
Reagents I-4


II. EXECUTIVE SUMMARY

1. MARKET DYNAMICS II-1
Outlook II-1
Biopharmaceuticals and Biosimilars to Fuel Growth II-2
Select Biologic Drugs Losing Patent Protection: 2013-2015 II-3
Regenerative Medicine Kindles Exciting Prospects II-3
Personalized Medicine Offers New Growth Avenues II-4
Industrial vs. Academic II-5

2. TRENDS AND ISSUES II-6
Mammalian Cell Culture Media on the Growth Curve II-6
3D Technology to Put a New Spin on In Vitro Cell Analyses II-6
Stem Cells and Vaccines - Key Drivers II-7
Increasing Applications of Adult Stem Cells to Drive Growth II-7
Growing Acceptance for Hi-Veg Culture Media II-7
Trend towards Media Optimization and Specialization II-8
Fed-Batch Cultures - A Big Hit with Large-Scale Bioprocessors II-8
Trend towards Serum-Free Media II-8
Pharmacokinetics to Drive Market Growth II-9
Bioresearch and Cell Culture in Protein Based Drug Development II-10
Sluggish Fetal Bovine Serum Market II-10
Specialty Media Demand on Rise II-11
Growth of Defined Media II-11
Regulations Prompt Change in Trends II-11
Outsourcing Trend to Drive Gains II-12
Factors Impacting Growth II-12
Business Models Driving the Need for Contract Manufacturing II-12
Target Sectors for Contract Manufacturers II-13
Other Trends II-13
Underlying Threat to Cell Culture Industry II-13

3. COMPETITIVE LANDSCAPE II-14
Table 1: Leading Players in the Global Cell Culture Supplies
Market (2013): Percentage Breakdown of Value Sales for
Affymetrix Inc., BD Biosciences, EMD Millipore, Life
Technologies Inc., SAFC Biosciences and Thermo Fisher
Scientific and Others (includes corresponding Graph/Chart) II-14

4. END-USE ANALYSIS II-15
End-Use Applications II-15
Cell Therapy II-15
Cell Therapy Applications II-16
Key Factors Affecting the Cell Therapy Market II-16
Future Trends II-16
Related Market Sectors II-16
Progenitor Cell Therapy II-16
Stem Cell Therapy II-17
Other Related Technologies II-18
Somatic Cell Nuclear Transfer (SCNT) II-18
Tissue Engineering II-18

5. CELL/TISSUE CULTURE: PHYSIOLOGICAL OVERVIEW II-19
Introduction II-19
History II-19
Plant Culture: The Timeline II-19
Plant Cell and Tissue Culture (PCTC) II-22
Plant Tissue Culture Techniques and Applications II-23
Cell/Tissue Culture Media, Sera and Reagents II-26
Classical Media II-27
Specialty Media II-27
Serum II-27
Fetal Bovine Serum II-27
Serum-Free Media II-27
Cell Culture Reagents II-28
Role of Tissue Culture in the Growth of Cell Types II-28
Equipment II-28
Storage and Preservation II-28
Maintenance II-29
Media and Growth Requirements II-30
Methods of Tissue Culture II-31
Preparation of Media II-31
Growth and Morphology II-31
Sub Culturing Adherent Cells II-31
Thawing Frozen Cells II-31
Freezing Cells II-31
3D Culture-Enabling Technologies II-32
Natural Scaffold Substrates II-32
Hydrogels II-32
Inert Non-Degradable Scaffolds II-32
Biodegradable Materials II-32
Cell Culture Contamination II-33
Chemical Contamination II-33
Biological Contamination II-35
Cross Contamination by Other Cell Cultures II-37
Consequences/Problems of Contamination II-37
Controlling Cell Culture Contamination II-38

6. PRODUCT INNOVATIONS/INTRODUCTIONS II-39
Pfanstiehl Introduces Non-Animal-Derived, cGMP- Produced
Galactose for Optimizing Cell Culture Media II-39
Cayman Chemical and 3D Biomatrix Introduce Perfecta3D® LDH
Cytotoxicity Assay Kit II-39
Lena Biosciences Launches SeedEZ II-39
AMSBIO Introduces 384-Well 3D Cell Culture Plates II-39
Irvine Scientific Launches New Cell Therapy Products II-39
Jeevan BioSciences Launches Neuro-X Tissue Culture Media II-39
Rainbow Scientific Introduces New Stem Cell Culture Systems II-39
BioSilta Launches EnPresso B Growth Systems II-40
EMD Millipore Introduces OsteoMAX-XFâ„¢ II-40
Thermo Fisher Scientific Launches HyCryo-STEM and HyClone
HyCryo Cryopreservation Media II-40
Sigma® Life Science Introduces Stemline® Pluripotent Culture
Medium II-40
Selexis Introduces BalanCDâ„¢ CHO SLX A II-40
Thermo Fisher Scientific Launches HyCell CHO Cell-Culture Medium II-40
PhoenixSongs Biologicals Launches Neural Cell Culture Media
System II-40
Corning Launches Corning cellgro II-40

7. RECENT INDUSTRY ACTIVITY II-41
Thermo Fisher Scientific Divests Select Biosciences Businesses
to GE Healthcare II-41
Thermo Fisher Acquires Life Technologies Corporation II-41
AvantBio Inks Manufacturing Supply Agreement with US-based
Company for Producing dAOF Cell Culture Systems II-41
Evotec Takes Over Cell Culture Service II-41
Lonza Inks Collaboration, Supply and Distribution Agreement
with Sartorius Stedim Biotech II-41
Transparent and Molecular Response Laboratories Extend
Original Validation Studies and Execution of Key Long Term
Collaboration Agreement II-41
Merck Takes Over Biochrom II-42
Merck KGaA Takes Over Beijing Skywing Technology II-42

8. FOCUS ON SELECT PLAYERS II-43
Affymetrix, Inc. (US) II-43
AMRESCO, Inc. (US) II-43
BD Biosciences (US) II-43
Cell Culture Technologies, LLC (Switzerland) II-44
Corning, Inc. (US) II-44
EMD Millipore (US) II-44
Irvine Scientific, Inc. (US) II-45
Lonza Biologics Plc (UK) II-45
MP Biomedicals LLC (US) II-45
ORIGIO a/s (Denmark) II-45
PromoCell GmbH (Germany) II-46
Sera Laboratories International Ltd (UK) II-46
Sigma-Aldrich Corporation (US) II-46
SAFC Biosciences, Inc. (US) II-47
Thermo Fisher Scientific, Inc. (US) II-47
Vitrolife AB (Sweden) II-47

9. GLOBAL MARKET PERSPECTIVE II-48
Table 2: World Recent Past, Current and Future Analysis for Cell
and Tissue Culture Supplies by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America,
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) II-48

Table 3: World Historic Review for Cell and Tissue Culture
Supplies by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-49

Table 4: World 15-Year Perspective for Cell and Tissue Culture
Supplies by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America, and Rest of World Markets for Years
2006, 2014 and 2020 (includes corresponding Graph/Chart) II-50
Cell and Tissue Culture Supplies Market by Product Segment II-51
Table 5: World Recent Past, Current and Future Analysis for
Media Cell and Tissue Culture Supplies by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) II-51

Table 6: World Historic Review for Media Cell and Tissue
Culture Supplies by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-52

Table 7: World 15-Year Perspective for Media Cell and Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America, and Rest of World Markets
for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) II-53

Table 8: World Recent Past, Current and Future Analysis for Sera
Cell and Tissue Culture Supplies by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America, and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) II-54

Table 9: World Historic Review for Sera Cell and Tissue
Culture Supplies by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-55

Table 10: World 15-Year Perspective for Sera Cell and Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America, and Rest of World Markets
for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) II-56

Table 11: World Recent Past, Current and Future Analysis for
Reagent Cell and Tissue Culture Supplies by Geographic Region
- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) II-57

Table 12: World Historic Review for Reagent Cell and Tissue
Culture Supplies by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-58

Table 13: World 15-Year Perspective for Reagent Cell and
Tissue Culture Supplies by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) II-59


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Cell and Tissue Culture Market III-1
Market Trends III-2
Trend towards Serum-Free Media III-2
Table 14: Leading Players in the US Cell Culture Media
Market (2013): Percentage Breakdown of Sales for
Sigma-Aldrich, Hyclone, Lonza Biologics, and Others
(includes corresponding Graph/Chart) III-2
Fetal Bovine Serum - On a Decline III-3
Market for Stem Cell Research III-3
End-Use Analysis III-3
Table 15: US Market for Cell Culture Reagents (2013):
Percentage Breakdown by End-Use for Academic, Industrial,
and Non-Academic (includes corresponding Graph/Chart) III-4
Regulatory Controls III-4
Guidelines Governing Use of Cell/Tissue Culture Reagents III-4
MSDS and Hazardous Information III-4
Toxic Substances Control Act III-5
Regulatory Environment III-5
Major FDA Regulations III-5
Strategic Corporate Developments III-5
Product Launches III-6
Key Players III-8
B.Market Analytics III-11
Table 16: The US Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-11

Table 17: The US Historic Review for Cell and Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-12

Table 18: The US 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-13

2. CANADA III-14
A.Market Analysis III-14
Current and Future Analysis III-14
B.Market Analytics III-15
Table 19: Canadian Recent Past, Current and Future Analysis
for Cell and Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2013
through 2020 (includes corresponding Graph/Chart) III-15

Table 20: Canadian Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-16

Table 21: Canadian 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-17

3. JAPAN III-18
Market Analysis III-18
Table 22: Japanese Recent Past, Current and Future Analysis
for Cell and Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2013
through 2020 (includes corresponding Graph/Chart) III-18

Table 23: Japanese Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-19

Table 24: Japanese 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-20

4. EUROPE III-21
A.Market Analysis III-21
Current and Future Analysis III-21
Product Launch III-21
Strategic Corporate Development III-21
B.Market Analytics III-22
Table 25: European Recent Past, Current and Future Analysis
for Cell and Tissue Culture Supplies by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-22

Table 26: European Historic Review for Cell and Tissue
Culture Supplies by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-23

Table 27: European 15-Year Perspective for Cell and Tissue
Culture Supplies by Geographic Region - Percentage Breakdown
of Dollar Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-24

Table 28: European Recent Past, Current and Future Analysis
for Cell and Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2013
through 2020 (includes corresponding Graph/Chart) III-25

Table 29: European Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-26

Table 30: European 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-27

4a. FRANCE III-28
Market Analysis III-28
Table 31: French Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-28

Table 32: French Historic Review for Cell and Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-29

Table 33: French 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-30

4b. GERMANY III-31
A.Market Analysis III-31
Current and Future Analysis III-31
Strategic Corporate Developments III-31
PromoCell GmbH - A Key Player III-32
B.Market Analytics III-33
Table 34: German Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-33

Table 35: German Historic Review for Cell and Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-34

Table 36: German 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-35

4c. ITALY III-36
Market Analysis III-36
Table 37: Italian Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-36

Table 38: Italian Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-37

Table 39: Italian 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-38

4d. THE UNITED KINGDOM III-39
A.Market Analysis III-39
Current and Future Analysis III-39
Product Launches III-39
Key Players III-40
B.Market Analytics III-41
Table 40: The UK Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-41

Table 41: The UK Historic Review for Cell and Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-42

Table 42: The UK 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-43

4e. SPAIN III-44
Market Analysis III-44
Table 43: Spanish Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-44

Table 44: Spanish Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-45

Table 45: Spanish 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-46

4f. RUSSIA III-47
Market Analysis III-47
Table 46: Russian Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-47

Table 47: Russian Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-48

Table 48: Russian 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-49

4g. REST OF EUROPE III-50
A.Market Analysis III-50
Current and Future Analysis III-50
Scenario in other European Countries III-50
Product Launch III-50
Key Players III-51
B.Market Analytics III-52
Table 49: Rest of Europe Recent Past, Current and Future
Analysis for Cell and Tissue Culture Supplies by Product
Segment - Media, Sera, and Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-52

Table 50: Rest of Europe Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-53

Table 51: Rest of Europe 15-Year Perspective for Cell and
Tissue Culture Supplies by Product Segment - Percentage
Breakdown of Dollar Sales for Media, Sera, and Reagents
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-54

5. ASIA-PACIFIC III-55
A.Market Analysis III-55
Current and Future Analysis III-55
Rise of Cell Culture in Asia III-55
B.Market Analytics III-56
By Region III-56
Table 52: Asia-Pacific Recent Past, Current and Future
Analysis for Cell and Tissue Culture Supplies by Geographic
Region - China, India, and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-56

Table 53: Asia-Pacific Historic Review for Cell and Tissue
Culture Supplies by Geographic Region - China, India, and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-57

Table 54: Asia-Pacific 15-Year Perspective for Cell and
Tissue Culture Supplies by Geographic Region - Percentage
Breakdown of Dollar Sales for China, India, and Rest of
Asia-Pacific Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-58
By Product Segment III-59
Table 55: Asia-Pacific Recent Past, Current and Future
Analysis for Cell and Tissue Culture Supplies by Product
Segment - Media, Sera, and Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for
Years 2013 through 2020 (includes corresponding
Graph/Chart) III-59

Table 56: Asia-Pacific Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-60

Table 57: Asia-Pacific 15-Year Perspective for Cell and
Tissue Culture Supplies by Product Segment - Percentage
Breakdown of Dollar Sales for Media, Sera, and Reagents
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-61

5a. CHINA III-62
A.Market Analysis III-62
Strategic Corporate Development III-62
B.Market Analytics III-63
Table 58: Chinese Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-63

Table 59: Chinese Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-64

Table 60: Chinese 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-65

5b. INDIA III-66
Market Analysis III-66
Table 61: Indian Recent Past, Current and Future Analysis for
Cell and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2013 through
2020 (includes corresponding Graph/Chart) III-67

Table 62: Indian Historic Review for Cell and Tissue Culture
Supplies by Product Segment - Media, Sera, and Reagents
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-68

Table 63: Indian 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-69

5c. REST OF ASIA-PACIFIC III-70
Market Analysis III-70
Table 64: Rest of Asia-Pacific Recent Past, Current and Future
Analysis for Cell and Tissue Culture Supplies by Product
Segment - Media, Sera, and Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-70

Table 65: Rest of Asia-Pacific Historic Review for Cell and
Tissue Culture Supplies by Product Segment - Media, Sera,
and Reagents Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-71

Table 66: Rest of Asia-Pacific 15-Year Perspective for Cell
and Tissue Culture Supplies by Product Segment - Percentage
Breakdown of Dollar Sales for Media, Sera, and Reagents
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-72

6. LATIN AMERICA III-73
A.Market Analysis III-73
Current and Future Analysis III-73
B.Market Analytics III-73
By Region III-73
Table 67: Latin American Recent Past, Current and Future
Analysis for Cell and Tissue Culture Supplies by Geographic
Region - Brazil and Rest of Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-73

Table 68: Latin American Historic Review for Cell and
Tissue Culture Supplies by Geographic Region - Brazil and
Rest of Latin America Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-74

Table 69: Latin American 15-Year Perspective for Cell and
Tissue Culture Supplies by Geographic Region - Percentage
Breakdown of Dollar Sales for Brazil and Rest of Latin
America Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-75
By Product Segment III-76
Table 70: Latin American Recent Past, Current and Future
Analysis for Cell and Tissue Culture Supplies by Product
Segment - Media, Sera, and Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for
Years 2013 through 2020 (includes corresponding
Graph/Chart) III-76

Table 71: Latin American Historic Review for Cell and
Tissue Culture Supplies by Product Segment - Media, Sera,
and Reagents Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-77

Table 72: Latin American 15-Year Perspective for Cell and
Tissue Culture Supplies by Product Segment - Percentage
Breakdown of Dollar Sales for Media, Sera, and Reagents
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-78

6a. BRAZIL III-79
Market Analysis III-79
Table 73: Brazilian Recent Past, Current and Future Analysis
for Cell and Tissue Culture Supplies by Product Segment -
Media, Sera, and Reagents Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2013
through 2020 (includes corresponding Graph/Chart) III-79

Table 74: Brazilian Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-80

Table 75: Brazilian 15-Year Perspective for Cell and Tissue
Culture Supplies by Product Segment - Percentage Breakdown
of Dollar Sales for Media, Sera, and Reagents Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) III-81

6b. REST OF LATIN AMERICA III-82
Market Analysis III-82
Table 76: Rest of Latin American Recent Past, Current and
Future Analysis for Cell and Tissue Culture Supplies by
Product Segment - Media, Sera, and Reagents Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-82

Table 77: Rest of Latin American Historic Review for Cell
and Tissue Culture Supplies by Product Segment - Media,
Sera, and Reagents Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2006 through
2012 (includes corresponding Graph/Chart) III-83

Table 78: Rest of Latin American 15-Year Perspective for
Cell and Tissue Culture Supplies by Product Segment -
Percentage Breakdown of Dollar Sales for Media, Sera, and
Reagents Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-84

7. REST OF WORLD III-85
Market Analysis III-85
Table 79: Rest of World Recent Past, Current and Future
Analysis for Cell and Tissue Culture Supplies by Product
Segment - Media, Sera, and Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-85

Table 80: Rest of World Historic Review for Cell and Tissue
Culture Supplies by Product Segment - Media, Sera, and
Reagents Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-86

Table 81: Rest of World 15-Year Perspective for Cell and
Tissue Culture Supplies by Product Segment - Percentage
Breakdown of Dollar Sales for Media, Sera, and Reagents
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-87


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 67 (including Divisions/Subsidiaries - 71)

The United States (42)
Canada (3)
Japan (1)
Europe (21)
- France (2)
- Germany (8)
- The United Kingdom (3)
- Rest of Europe (8)
Asia-Pacific (Excluding Japan) (3)
Middle East (1)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.